[English] 日本語
Yorodumi- EMDB-71987: Unlatched-state naloxone-mu opioid receptor-Gi GDPbS complex (reb... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Unlatched-state naloxone-mu opioid receptor-Gi GDPbS complex (rebound) - Locally refined Gi map | |||||||||
Map data | Unlatched-state naloxone-mu opioid receptor-Gi GDPbS complex (rebound) - Locally refined Gi map | |||||||||
Sample |
| |||||||||
Keywords | G protein coupled receptor / Mu Opioid receptor / Naloxone / MEMBRANE PROTEIN | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.0 Å | |||||||||
Authors | Gati C / Khan S / Han GW | |||||||||
| Funding support | United States, 2 items
| |||||||||
Citation | Journal: Nature / Year: 2025Title: Structural snapshots capture nucleotide release at the μ-opioid receptor. Authors: Saif Khan / Aaliyah S Tyson / Mohsen Ranjbar / Zixin Zhang / Jaskaran Singh / Gye Won Han / Cornelius Gati / ![]() Abstract: As a member of the G protein-coupled receptor superfamily, the μ-opioid receptor (MOR) activates heterotrimeric G proteins by opening the Gα α-helical domain (AHD) to enable GDP-GTP exchange, ...As a member of the G protein-coupled receptor superfamily, the μ-opioid receptor (MOR) activates heterotrimeric G proteins by opening the Gα α-helical domain (AHD) to enable GDP-GTP exchange, with GDP release representing the rate-limiting step. Here, using pharmacological assays, we show that agonist efficacy correlates with decreased GDP affinity, promoting GTP exchange, whereas antagonists increase GDP affinity, dampening activation. Further investigating this phenomenon, we provide 8 unique structural models and 16 cryogenic electron microscopy maps of MOR with naloxone or loperamide, capturing several intermediate conformations along the activation pathway. These include four GDP-bound states with previously undescribed receptor-G protein interfaces, AHD arrangements and transitions in the nucleotide-binding pocket required for GDP release. Naloxone stalls MOR in a 'latent' state, whereas loperamide promotes an 'engaged' state, which is structurally poised for opening of the AHD domain and subsequent GDP release. These findings, supported by molecular dynamics simulations, identify GDP-bound intermediates and AHD conformations as key determinants of nucleotide exchange rates, providing structural and mechanistic insights into G protein activation and ligand efficacy with broad implications for G protein-coupled receptor pharmacology. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_71987.map.gz | 59.4 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-71987-v30.xml emd-71987.xml | 19.9 KB 19.9 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_71987_fsc.xml | 8.4 KB | Display | FSC data file |
| Images | emd_71987.png | 23.3 KB | ||
| Filedesc metadata | emd-71987.cif.gz | 4.6 KB | ||
| Others | emd_71987_additional_1.map.gz emd_71987_half_map_1.map.gz emd_71987_half_map_2.map.gz | 32.4 MB 59.4 MB 59.4 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-71987 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-71987 | HTTPS FTP |
-Validation report
| Summary document | emd_71987_validation.pdf.gz | 872.5 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_71987_full_validation.pdf.gz | 872.1 KB | Display | |
| Data in XML | emd_71987_validation.xml.gz | 16 KB | Display | |
| Data in CIF | emd_71987_validation.cif.gz | 20.5 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-71987 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-71987 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_71987.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Unlatched-state naloxone-mu opioid receptor-Gi GDPbS complex (rebound) - Locally refined Gi map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.294 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Additional map: Additional Map
| File | emd_71987_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Additional Map | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half Map A
| File | emd_71987_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half Map A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half Map B
| File | emd_71987_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half Map B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Naloxone-mu opioid receptor in complex with Gai-GDPbS, Gb1 and Gg2
| Entire | Name: Naloxone-mu opioid receptor in complex with Gai-GDPbS, Gb1 and Gg2 |
|---|---|
| Components |
|
-Supramolecule #1: Naloxone-mu opioid receptor in complex with Gai-GDPbS, Gb1 and Gg2
| Supramolecule | Name: Naloxone-mu opioid receptor in complex with Gai-GDPbS, Gb1 and Gg2 type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#4 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 130 kDa/nm |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7.5 Component:
| |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Support film - Material: GOLD / Support film - topology: HOLEY ARRAY | |||||||||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 95 % / Chamber temperature: 298 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Number grids imaged: 1 / Average electron dose: 51.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.5 µm |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
United States, 2 items
Citation







































Z (Sec.)
Y (Row.)
X (Col.)












































Processing
FIELD EMISSION GUN

